1α,25-Dihydroxyvitamin D3 is a preventive factor in the metastasis of lung cancer

被引:109
|
作者
Nakagawa, K
Kawaura, A
Kato, S
Takeda, E
Okano, T
机构
[1] Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan
[2] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan
[3] Univ Tokushima, Sch Med, Dept Clin Nutr, Tokushima, Japan
关键词
D O I
10.1093/carcin/bgh332
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1alpha,25-Dihydroxyvitamin D-3 [1alpha,25(OH)(2)D-3], the major regulator of calcium homeostasis, has potent antiproliferative and anti-invasive properties in vitro in cancer cells. Studies in vivo demonstrated that 1alpha,25(OH)(2)D-3 slows the progression of breast, prostate and other carcinomas. A key question is whether 1alpha,25(OH)(2)D-3 exerts its anticarcinogenic effects in vivo by a mechanism that is dependent on its capacity to limit the proliferation and invasiveness of cancer cells in vitro. It has not been clear whether the calcemic activity and regulation of the host defenses by 1alpha,25(OH)(2)D-3 contribute to the effect on cancer cells. In this study we have focused on the influence of 1alpha,25(OH)(2)D-3 on the metastasis of lung cancer, without involvement of the calcemic activity and other effects of 1alpha,25(OH)(2)D-3 in the host. We used metastatic Lewis lung carcinoma cells expressing green fluorescent protein (LLC-GFP cells) and examined metastatic activity in vitamin D receptor (VDR) null mutant (VDR-/-) mice and their wild-type counterparts (VDR+/+ mice). VDR-/- mice exhibit hypocalcemia and extremely high serum levels of 1alpha,25(OH)(2)D-3. We expected that serum 1alpha,25(OH)(2)D-3 would act in vivo to directly inhibit the metastatic growth of VDR-positive LLC-GFP cells in VDR-/- mice. The metastatic activities of LLC-GFP cells were remarkably reduced in VDR-/- mice compared with VDR+/+ mice. To test the hypothesis that serum 1alpha,25(OH)(2)D-3 is an intrinsic factor that inhibits metastatic growth of lung cancer cells, we corrected hypocalcemia and/or hypervitaminosis D in VDR-/- mice by dietary manipulation. The metastatic growth of LLC-GFP cells was remarkably reduced in response to serum levels of 1alpha,25(OH)(2)D-3, but not to serum calcium levels. Furthermore, we found that VDR+/+ mice fed the manipulated diets displayed an apparent inverse relationship between the physiological levels of serum 1alpha,25(OH)(2)D-3 (8-15 pg/ml) and tumorigenesis. Here we show that 1alpha,25(OH)(2)D-3 inhibits the metastatic growth of lung cancer cells in a defined animal model.
引用
收藏
页码:429 / 440
页数:12
相关论文
共 50 条
  • [31] Inhibition of 25-hydroxyvitamin D3 production by 1,25-dihydroxyvitamin D3 in rats
    Reinholz, CG
    DeLuca, HF
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 355 (01) : 77 - 83
  • [32] 1α,25-dihydroxy-3-epi-vitamin D3:: In vivo metabolite of 1α,25-dihydroxyvitamin D3 in rats
    Sekimoto, H
    Siu-Caldera, ML
    Weiskopf, A
    Vouros, P
    Muralidharan, KR
    Okamura, WH
    Uskokovic, MR
    Reddy, GS
    FEBS LETTERS, 1999, 448 (2-3) : 278 - 282
  • [33] 1α,25-Dihydroxyvitamin D3 inhibits neutrophil recruitment in hamster model of acute lung injury
    Takano, Yasuhiro
    Mitsuhashi, Hiroaki
    Ueno, Koichi
    STEROIDS, 2011, 76 (12) : 1305 - 1309
  • [34] 1β,25-Dihydroxyvitamin D3: A new vitamin D metabolite in human serum
    Pauwels, Steven
    Jans, Ivo
    Billen, Jaak
    Heijboer, Annemieke
    Verstuyf, Annemieke
    Carmeliet, Geert
    Mathieu, Chantal
    Maestro, Miguel
    Waelkens, Etienne
    Evenepoel, Pieter
    Bouillon, Roger
    Vanderschueren, Dirk
    Vermeersch, Pieter
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 173 : 341 - 348
  • [35] 1α,25-dihydroxyvitamin D3-3β-(2)-bromoacetate, an affinity labeling derivative of 1α,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells
    Swamy, N
    Persons, KS
    Chen, TC
    Ray, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (05) : 909 - 916
  • [36] Attenuation of hyperoxia-induced lung injury in neonatal rats by 1α,25-Dihydroxyvitamin D3
    Chen, Yan
    Li, Qiong
    Liu, Yalan
    Shu, Li
    Wang, Na
    Wu, Yipin
    Sun, Xue
    Wang, Lin
    EXPERIMENTAL LUNG RESEARCH, 2015, 41 (06) : 344 - 352
  • [37] Analogs of 1α,25-dihydroxyvitamin D3 as novel inhibitors of renin biosynthesis
    Qiao, GL
    Kong, J
    Uskokovic, M
    Li, YC
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 96 (01): : 59 - 66
  • [38] Metabolites and analogs of 1α,25-dihydroxyvitamin D3:: evaluation of actions in bone
    Kadiyala, S
    Nagaba, S
    Takeuchi, K
    Yukihiro, S
    Qiu, WP
    Eyes, ST
    Uskokovic, MR
    Posner, GH
    Reddy, GS
    Guggino, SE
    STEROIDS, 2001, 66 (3-5) : 347 - 355
  • [39] An efficient synthesis of 1α,25-dihydroxyvitamin D3 LC-biotin
    Kattner, Lars
    Bernardi, Dan
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 173 : 89 - 92
  • [40] Induction of regulatory dendritic cells by dexamethasone and 1α,25-dihydroxyvitamin D3
    Pedersen, AE
    Gad, M
    Walter, MR
    Claesson, MH
    IMMUNOLOGY LETTERS, 2004, 91 (01) : 63 - 69